Kevin M. Ban - Oct 25, 2023 Form 4 Insider Report for Walgreens Boots Alliance, Inc. (WBA)

Role
EVP, Chief Medical Officer
Signature
/s/ Kevin M. Ban by Cherita Thomas, Attorney-in-Fact
Stock symbol
WBA
Transactions as of
Oct 25, 2023
Transactions value $
-$41,308
Form type
4
Date filed
10/27/2023, 07:43 PM
Previous filing
Nov 22, 2022
Next filing
Nov 3, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WBA Common Stock Award $0 +5.8K +19.87% $0.00 35K Oct 25, 2023 Direct F1, F2
transaction WBA Common Stock Tax liability -$41.3K -1.93K -5.53% $21.37 33K Oct 25, 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issued upon settlement of performance share award (not a derivative security within the meaning of Rule 16a-1(c)) granted on November 1, 2020 under the Walgreens Boots Alliance, Inc. 2013 Omnibus Incentive Plan.
F2 Includes shares underlying restricted stock units issued in lieu of dividends (through October 15, 2023) on outstanding restricted stock units.
F3 Disposition relating to the satisfaction of tax withholding obligations upon the settlement of award granted in accordance with Rule 16b-3.